US Archives - Page 105 of 157 - European Medical Journal

Top Dietary Choices Following Ovarian Cancer Survival

A new study has found that diet may play a key role in survival for women diagnosed with early-stage ovarian cancer.

AI Imaging Revolutionizes Early Autism Detection

A new review highlights how artificial intelligence (AI) and structural MRI (sMRI) are transforming early diagnosis of Autism Spectrum Disorder (ASD), offering hope for earlier interventions and improved outcomes.

LA Wildfires Spark Surge in Smoke-Related ER Visits

The Los Angeles County wildfires in January 2025 had a notable impact on healthcare utilization, with emergency department (ED) visits decreasing by 9% while wildfire-associated visits spiked eightfold.

Mpox Risk Profile and Protective Factors Defined in Latest Analysis

A systematic review and meta-analysis examining risk factors associated with Mpox infection has provided important insights into transmission patterns and protective factors.

Premature Death Risk Doubled with Serious Mental Illness: New York Study

Adults with serious mental illness (SMI) living in New York City are dying significantly younger than their peers, according to a new study.

AI and Real-World Data Transform Cancer Prognosis

The power of explainable artificial intelligence (xAI) combined with multimodal real-world data (RWD) to improve cancer prognosis across multiple cancer types was explored in a new study.

Psychedelic Psychotherapy: Promise and Pitfalls

A new analysis of psychedelic-assisted psychotherapy (PAP) research calls for greater methodological rigor and ethical reflection as the field continues to evolve.

A Game-Changer for Precision Medicine in Rheumatoid Arthritis

The potential of high-content imaging as a game-changer for precision medicine in rheumatoid arthritis (RA) has been highlighted in a new study.

Strengthening Vaccine Strategies for Mpox

Recent research into monkeypox (mpox) highlights critical gaps in vaccination coverage and infectious disease preparedness, raising concerns about future outbreaks.

LS-SCLC Immunotherapy Treatment Recommended for Approval

A new treatment for limited-stage small cell lung cancer (LS-SCLC) has been recommended for approval in the European Union following positive results from a Phase III trial.